Local search for San Diego places

Built by local search architects

4SanDiego is a focused search engine for San Diego residents, businesses, and visitors. It combines multiple indexes, curated local sources, and specialized AI to surface results that matter in San Diego: local businesses, neighborhood guides, events, government resources, maps, and community reporting. Use 4SanDiego when you need precise local context and practical recommendations. Part of the 4SEARCH network of topic specific search engines.

Pro Sports

More
sports.yahoo.com

Los Angeles Chargers completely overhaul their defense and offensive line during latest 7-round 2027 NFL mock draft

The latest 7-round 2027 NFL mock draft gifts the Los Angeles Chargers an overhaul on the defense and offensive line. It's quite the haul. The Los Angeles Chargers have several opportunities to add young talent to their roster in the 2027 NFL Draft, and this seven-round mock draft focuses on strengthening the secondary, improving the offensive and defensive lines, and adding depth at wide receiver and tight end. Using the A to Z Sports Mock Draft Simulator, I put together a nine-player class for Los Angeles, beginning with a potential first-round difference-maker from Notre Dame and continuing with several intriguing developmental prospects on Day 2 and Day 3. The Chargers' biggest priorities in this projection are adding another talented cornerback, investing in the trenches on both sides of the ball, and finding young offensive weapons who can develop alongside the team's existing…

1,064 words2 outlets
More in Pro Sports

Employers and Institutions

More
247wallst.com

Aspen Neuroscience (ASPE) sets $15-$17 IPO range for $150 million Parkinson's cell therapy raise

As seen on the 24/7 Wall St. homepage on October 26, 2026. Second amendment sets $15-$17 range on a $150 million deal Aspen Neuroscience penciled in a $15 to $17 range on 9.375 million shares, a roughly $150 million Nasdaq raise for its patient-derived cell therapy work in Parkinson's. Leerink, UBS, Piper Sandler, Stifel and Oppenheimer are running the book, which sets pricing up within days. Aspen Neuroscience has filed a second amendment to its S-1 with the SEC, establishing a formal price range of $15 to $17 per share and putting the total raise at roughly $150 million. Pricing is expected within days, so the window for investors tracking this debut is narrow. The company is developing patient-derived cell therapy for Parkinson's disease, a field that draws attention precisely because it aims to use a patient's own cells to create a personalized treatment. That approach sits at a…

662 words2 outlets
More in Employers and Institutions

Around the Region

More
prnewswire.com

Globe Life Inc. Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Globe Life Inc. (GL)

Oct 26, 2026, 19:20 ET Globe Life disclosed roughly $7 million in excess prior-period Medicare Supplement claims linked to a federal CMS processing delay, and GL shares fell over 8%. The investigation concerns what investors were told about the Company's exposure to CMS claims processing. The claims landed in United American, the Globe Life division that writes Medicare Supplement coverage. For the quarter ended September 30, 2026, United American reported a health underwriting margin of negative $6 million on $219 million in health premiums. The Company said the excess claims related to prior periods and were paid because of the CMS processing delay. Globe Life investors who suffered losses are encouraged to request a free review of your GL losses or call (888) SueWallSt. Frequently Asked Questions About the GL InvestigationQ: Who is eligible to participate in the GL investigation? A…

448 words2 outlets
More in Around the Region

Colleges and Universities

More
poundsterlinglive.com

Pound-to-Dollar Week Ahead Forecast: Is The Recovery Done?

The Pound to Dollar exchange rate has run into its 100-day moving average and spent the past week unable to break clear of it, a sign the rebound from the October lows is losing steam. A stall at this level is understandable given what lies ahead, with a Fed decision and a UK Budget set to make for an eventful week. From a technical perspective, the 100-day moving average, shown in blue, has capped GBP/USD throughout the past week, and that resistance could thwart further gains: GBP/USD daily chart. Image © Pound Sterling Live, chart created with TradingView. GBP/USD trades at 1.3373 at the start of the week, just beneath the 100-day at 1.3390. The pair pushed above the average intraday on four straight sessions last week, peaking at 1.3419 on Thursday, but it failed to build on any of those moves. What does the 100-day denote? It tracks the average closing price over roughly five…

904 words2 outlets
More in Colleges and Universities

More topics